Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001993374 | SCV002231193 | pathogenic | not provided | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 31 of the COL4A1 gene. RNA analysis indicates that disruption of this splice site induces altered splicing and likely results in a shortened protein product. This variant is not present in population databases (gnomAD no frequency). Disruption of this splice site has been observed in individual(s) with clinical features of COL4A1-related conditions (PMID: 25706114). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 1451906). Studies have shown that disruption of this splice site results in skipping of exon 31, but is expected to preserve the integrity of the reading-frame (PMID: 25706114). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV005006307 | SCV005632907 | likely pathogenic | Autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome; Brain small vessel disease 1 with or without ocular anomalies; Hemorrhage, intracerebral, susceptibility to; Retinal arterial tortuosity; Microangiopathy and leukoencephalopathy, pontine, autosomal dominant | 2024-06-03 | criteria provided, single submitter | clinical testing |